http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-206040-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 1989-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a83fde9e39f4db7827c4d16b11868b
publicationDate 1992-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-206040-B
titleOfInvention Pharmaceutical compositions comprising process for producing 5-aryl-substituted-imidazo (2,1a)isolinolines suitable for treating respiratory hypersensitivity or preventing asthma
abstract Compounds of formula In wherein the substituents have various significances, are indicated for use in controlling hyperreactive airways induced by PAF or allergen and in the prophylactic treatment of asthma. A preferred route of administration is by inhalation.
priorityDate 1988-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14676791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14676829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452272323
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453571051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14676809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448867060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454196114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425539605
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416031844
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6V115
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15442
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454621994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID597765
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2RVI8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19861867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414877441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453591021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14676831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503

Total number of triples: 51.